STAT Virtual Event | How to Increase Diversity in Clinical Trials: Strategies & Tools
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us
TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“Revive” or the “Company”) announces that it has completed the second
How remnant cholesterol (remnant-C) levels are associated with the risk of developing dementia using a large dataset from South Korea.